Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
Veru Inc. (NASDAQ:VERU) shares jumped on Tuesday after the company disclosed the sale of its FC2 Female Condom (Internal ...
Biopharma company to cut 90% of its jobs after sale
A clinical stage biopharma firm in Miami is slashing its headcount after selling its female condom business to an investment ...
Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...